LD-2 disclosure · 4th Quarter - Report
DRAGONFLY THERAPEUTICS, INC.
via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Income$30Kfee reported
Client
- Name
- DRAGONFLY THERAPEUTICS, INC.
- Description
- Clinical-stage biopharmaceutical company
- Location
- Massachusetts · United States of America
Registrant
- Firm
- FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
- Description
- Legislative and public affairs firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueTaxation/Internal Revenue Code
Lobbying related to deductibility of research and development expenses.
LobbyistsPAUL POTEET · RACHEL ALEXANDER
TargetedSENATE · HOUSE OF REPRESENTATIVES